CD274 and neoplasm: In the TME, PD‐1 and PD‐L1 are a typical pair of immune checkpoints.[101] During tumor development, high expression of PD‐L1 on the surface of tumor cells binds to the PD‐1 receptor of T cells, inhibits its immune function and allows tumors to escape from immune monitoring and killing.